This Subcontract opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Adenovirus Vaccine Supply (Type 4 and Type 7, Live)

Closed

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0247

Solicitation SPE2DP-27-T-0247 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one bottle of Hydrogen Peroxide Topical Solution, USP. The required item is a 3% stabilized topical solution for external use, provided in a 473 milliliter bottle. The delivery is required within 20 days after receipt of the order, with the place of performance and delivery located in Eastover, South Carolina. Inspection and acceptance will occur at the destination in accordance with FAR 52.246-2. The product is regulated by the FDA and classified as a hazardous material, requiring a current Material Safety Data Sheet to be provided to the DLA electronic mailbox and included with each shipment. Packaging must comply with MIL-STD-2073-1E, Special Packaging Instructions MPPWN00001, and Medical Marking Standard No. 1. For shipments via military aircraft, compliance with DLAI 4145.3 is mandatory. Additionally, the contractor must provide a signed certification on DD Form 250 confirming that the package configuration meets 49 CFR and ICAO or IMDG requirements. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and receiving reports. The contract incorporates several federal regulations, including the Buy American and Balance of Payments Program (DFARS 252.225-7001), safeguarding of covered defense information (DFARS 252.204-7012), and prohibitions on certain telecommunications equipment (DFARS 252.204-7018). Offerors must also validate their representations and certifications within the System for Award Management.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Mechanical Food Refrigerator SupplierThis subcontract involves the sourcing and manufacture of mechanical food refrigerators for prime contractors supporting DLA Troop Support subsistence supply contracts. The supplier is responsible for ensuring all equipment meets the specific requirements of NSN 4110016255318. Additionally, the contractor must adhere to strict military standards for packaging and marking, specifically MIL-STD-2073-1E and MIL-STD-129. The scope of work concludes with the delivery of the packaged and marked refrigerators to the DLA warehouse located in Tracy, California. This effort is managed under the Department of Defense through the Subsistence FSE Supply Chain, falling under NAICS code 325412.

SUBSISTENCE FSE SUPPLY CHAIN

POSTED

DEADLINE

Supply of Berry Flavored Oral Rehydration Salts (ORS)This subcontract involves the supply of berry-flavored electrolyte oral hydration powder to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The product must be manufactured using pharmaceutical-grade electrolytes, including specific amounts of sodium, potassium, citrate, magnesium, and zinc, and must be delivered in moisture-resistant packets. Each delivery consists of one package containing 100 packets. To ensure quality and compliance, the powder must adhere to FDA standards and meet the specifications of NSN 6505-01-646-2701. The contract falls under NAICS code 325412, with the place of performance located at FPO 96661. Interested parties should note the response deadline of November 10, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Praziquantel Tablets (NSN 6505011684445)This subcontract involves the supply of Praziquantel tablets, 600 MG, 6S, for prime contractors under Department of Defense supply contracts managed by the Medical Supply Chain Pharm FSA. The provider is responsible for manufacturing or sourcing medication that meets NSN 6505011684445 specifications, ensuring all products are delivered in sealed unit containers and commercial exterior shipping containers via common carrier to the destination point at Cannon AFB. The agreement requires strict adherence to pharmaceutical standards and compliance with the Buy American Act. Operating under NAICS code 325412, the contract specifies a response deadline of November 10, 2026, for the procurement of the required quantities of medication.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Egg-Free Influenza Vaccine SupplierThis subcontract involves the supply of FDA-approved, injectable egg-free influenza vaccines for adults aged 18 and older to support prime contractors on Department of Defense medical supply contracts. The supplier is responsible for manufacturing or sourcing the 2027-2028 formula vaccines, which must be packaged in 0.5 ML prefilled syringes with 10 syringes per package in accordance with CDC ACIP recommendations. To qualify, the provider must utilize FDA-approved biological manufacturing facilities and maintain strict compliance with Good Manufacturing Practices. The contract requires the delivery of 33,000 packages to the Defense Depot located in New Cumberland, Pennsylvania. This opportunity is managed under the Medical Supply Chain Pharm FSA for the Department of Defense.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Friction Lining (NSN 2530-01-447-6189)This subcontract involves the manufacture and supply of friction lining materials under NSN 2530-01-447-6189 to support prime contractors for the DLA Weapons Support LSO Combat Vehicles and Armament. The selected provider must ensure all materials strictly adhere to the Buy American Act and Berry Amendment requirements. Physical deliveries are to be made to DLA DIST San Joaquin in Tracy, California, with all packaging and marking performed according to MIL-STD-2073-1E and MIL-STD-129 standards. Rigorous security and regulatory compliance are mandatory for this engagement, including ITAR and EAR adherence. Additionally, the contractor must meet CMMC Level 2 and NIST SP 800-171 cybersecurity standards. Interested parties must submit their responses by November 16, 2026, for this Department of Defense requirement categorized under NAICS code 325412.

DLA WEAPONS SUPPORT LSO COMBAT VEHICLES AND ARMAMENT

POSTED

DEADLINE

Supply of Zinc Oxide Ointment, USPThis subcontract involves the supply of 20% Zinc Oxide topical skin protectant ointment for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The contractor is responsible for manufacturing or procuring ointment that adheres to USP standards, packaged in 1oz collapsible tubes. Strict quality controls are required, including maintaining storage temperatures at or below 30 degrees Celsius and ensuring full compliance with FDA regulations. Logistical requirements include adherence to Medical Marking Standard No. 1 and MIL-STD-129 for all packaging. The contract specifies a delivery requirement of 10 collapsible tubes within 15 days of an order. This opportunity falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Bupivacaine Hydrochloride Injection SupplierThis subcontract involves the supply of 2,000 vials of Bupivacaine Hydrochloride Injection USP, 0.5%, in 50 ML quantities for prime contractors supporting DLA Troop Support Medical Supply Chain Pharm FSA projects. The Department of Defense requires that all products be manufactured or procured in accordance with USP standards and the DLA Master List of Technical and Quality Requirements. To be eligible, the supplier must utilize FDA-approved manufacturing facilities and maintain valid USP certification. The place of performance for this contract is located at Fort Bragg, North Carolina, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturer of Lidocaine Hydrochloride and Dextrose InjectionThis subcontract with the Department of Defense Medical Supply Chain Pharmacy FSA involves the manufacture and supply of sterile, nonpyrogenic injectable medication for prime contractors. The scope of work requires the production of a solution containing 2g Lidocaine Hydrochloride USP and 5g Hydrous Dextrose USP at a 4 mg/mL concentration, filled into 500 ML single-dose bags. To ensure patient safety and quality, the manufacturing process must utilize latex-free, DEHP-free, and PVC-free systems within a sterile cleanroom environment. The selected provider must maintain a valid FDA license and strictly adhere to USP standards. Deliverables consist of packages containing 24 single-dose bags each. This opportunity falls under NAICS code 325412 and is associated with performance in APO 09227.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lyophilized Varicella Virus Vaccine LiveThis subcontract involves the manufacture and supply of lyophilized Varicella Virus Vaccine Live for the Department of Defense Medical Supply Chain Pharm FSA. The contractor is responsible for providing packages containing 10 single-dose vials of live vaccine and 10 vials of diluent, identified by NSN 6505-01-413-1331. To ensure product integrity, the vaccine must be maintained in cold-chain storage between -50C and -15C and packaged according to MIL-STD-2073-1E standards. The selected provider must hold FDA-regulated drug manufacturing certification to qualify for the project. The scope of work requires the delivery of one package FOB Destination to Japan. This opportunity falls under NAICS code 325412 and is managed through DLA Troop Support.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of 4% Chlorhexidine Gluconate Surgical DetergentThis subcontract involves the supply of FDA-regulated 4% chlorhexidine gluconate surgical detergent to support prime contractors on Department of Defense projects under the DLA Troop Support Medical Supply Chain. The product must strictly adhere to NSN 6505011013759 specifications and be delivered in sealed 8 oz bottles to Fort Bragg, North Carolina. Compliance requirements include strict adherence to Medical Marking Standard No. 1 and MIL-STD-2073-1E for packaging. Additionally, the supplier must manage shelf-life constraints, ensuring a total shelf life of 24 months with at least 21 months remaining at the time of delivery. The opportunity is categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Self-Seal Sterilization PouchesThis subcontract involves the manufacture and supply of self-seal sterilization pouches for prime contractors supporting DLA Troop Support medical supply contracts. The pouches must have nominal dimensions of 10.250 by 4.000 inches and adhere to Medical Marking Standard No. 1. Packaging requirements specify that units be packed in boxes of 500 in accordance with MIL-STD-2073-1E and RP001 palletization standards. The Department of Defense Medical Supply Chain FSH is the overseeing agency for this requirement, which entails the delivery of 30 boxes of pouches on a FOB Destination basis. Performance for this contract is located at FPO 09566-4008 under NAICS code 325412.

MEDICAL SUPPLY CHAIIN FSH

POSTED

1 day ago

DEADLINE

in 7 days

AI Contract Overview

The contract pertains to the supply of 54 packages of live adenovirus vaccine, specifically Type 4 and Type 7, manufactured by the entity with CAGE code 0AZ22 and identified by NDC 51285-0138-50. This subcontract, issued under the Defense Logistics Agency, a component of the Department of Defense, supports military health readiness by ensuring the availability of critical vaccines for personnel. The transaction is governed under NAICS code 325412, which classifies it within the pharmaceutical and medicine manufacturing sector. Though the solicitation number is not provided, the award is publicly accessible via the DIBBS system using the referenced contract and delivery identifiers. The place of performance and point of contact details are unspecified, suggesting logistical arrangements may be managed internally or through standard DLA protocols. The contract was posted on July 14, 2026, indicating an anticipated fulfillment timeline aligned with future operational needs.